VICP Vicapsys Life Sciences, Inc.
Fundamentals / CIK 0001468639 / USDVicapsys Life Sciences, Inc. reported $90K in total assets and a net loss of $1.35M through December 31, 2023 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VICP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2023-- Dec 31, 2023
-
Operating Income FY 2023-$1.11M Operating profit
-
Net Income FY 2023-$1.35M GAAP bottom line
-
Diluted EPS FY 2023-$0.04 Split-adjusted
-
Free Cash Flow FY 2023-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2024$90K Total debt: --
Annual revenue and net income
5 fiscal years (2019 to 2023), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Research & Development | $15K | $13K | $18K | $102K | $99K |
| Total Operating Expenses | $1.05M | $985K | $337K | $766K | $1.03M |
| Operating Income | -$1.05M | -$985K | -$337K | -$766K | -- |
| Interest Expense | $20K | -- | -- | -- | -- |
| Income Before Tax | -$1.18M | -$985K | -$237K | -$766K | -$1.03M |
| Net Income | -$1.18M | -$985K | -$237K | -$766K | -$1.41M |
| Basic EPS | -$0.03 | -$0.03 | -$0.01 | -$0.04 | -$0.13 |
| Diluted EPS | -$0.03 | -$0.03 | -$0.01 | -$0.04 | -$0.13 |
| Basic Shares Outstanding | 34.5M | 30.6M | 17.7M | 17.5M | 11.4M |
| Diluted Shares Outstanding | 34.5M | 30.6M | 17.7M | 17.5M | 11.4M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $3.7K | $10K | $344 | $0 | $3.3K | $2.0K | $10K | $0 |
| Total Operating Expenses | $199K | $182K | $204K | $527K | $175K | $136K | $211K | $493K |
| Operating Income | -$199K | -$182K | -$204K | -$527K | -$175K | -$136K | -$211K | -$493K |
| Interest Expense | $37K | $8.2K | -$37K | -- | $10.0K | -- | -- | -- |
| Income Before Tax | -$236K | -$190K | -$327K | -$595K | -$240K | -$136K | -$211K | -$493K |
| Net Income | -$236K | -$190K | -$327K | -$595K | -$240K | -$136K | -$211K | -$493K |
| Basic EPS | -$0.01 | -$0.01 | -$0.01 | -- | -$0.01 | $0.00 | -$0.01 | -- |
| Diluted EPS | -$0.01 | -$0.01 | -$0.01 | -- | -$0.01 | $0.00 | -$0.01 | -- |
| Basic Shares Outstanding | 34.3M | 34.2M | 32.1M | -- | 34.4M | 35.3M | 34.6M | -- |
| Diluted Shares Outstanding | 34.3M | 34.2M | 32.1M | -- | 34.4M | 35.3M | 34.6M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $9.4K | $14K | $217K | $1.3K | $264K |
| Cash & Short-Term Investments | $9.4K | $14K | $217K | $1.3K | $264K |
| Total Current Assets | $40K | $72K | $223K | $1.3K | $264K |
| Intangible Assets | -- | -- | $372K | $403K | $434K |
| Total Non-Current Assets | $0 | $0 | $372K | $403K | $434K |
| Total Assets | $40K | $72K | $594K | $404K | $698K |
| Accounts Payable | $537K | $272K | $488K | $502K | $396K |
| Short-Term Debt | $19K | -- | -- | -- | -- |
| Total Current Liabilities | $1.97M | $1.02M | $716K | $853K | $396K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.97M | $1.02M | $716K | $853K | $396K |
| Total Debt (incl. Leases) | $19K | -- | -- | -- | -- |
| Common Stock | $32K | $31K | $20K | $17K | $17K |
| Retained Earnings | -$16.30M | -$15.12M | -$14.13M | -$13.89M | -$13.13M |
| Total Stockholders' Equity | -$1.93M | -$951K | -$122K | -$449K | $302K |
| Total Equity | -$1.93M | -$951K | -$122K | -$449K | $302K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2024-09-30 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $90K | $9.4K | $54K | $231K | $4.1K | $14K | $26K | $17K |
| Cash & Short-Term Investments | $90K | $9.4K | $54K | $231K | $4.1K | $14K | $26K | $17K |
| Total Current Assets | $90K | $40K | $208K | $378K | $63K | $72K | $36K | $26K |
| Intangible Assets | -- | -- | -- | -- | -- | -- | $348K | $356K |
| Total Non-Current Assets | $0 | $0 | $0 | $0 | $0 | $0 | $348K | $356K |
| Total Assets | $90K | $40K | $208K | $378K | $63K | $72K | $384K | $382K |
| Accounts Payable | -- | $537K | $447K | $427K | $371K | $272K | $572K | $566K |
| Short-Term Debt | -- | $19K | $37K | $54K | -- | -- | -- | -- |
| Total Current Liabilities | $2.74M | $1.97M | $1.54M | $1.47M | $1.20M | $1.02M | $904K | $849K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.74M | $1.97M | $1.54M | $1.47M | $1.20M | $1.02M | $904K | $849K |
| Total Debt (incl. Leases) | -- | $19K | $37K | $54K | -- | -- | -- | -- |
| Common Stock | $32K | $32K | $32K | $31K | $31K | $31K | $31K | $31K |
| Retained Earnings | -$17.05M | -$16.30M | -$15.70M | -$15.46M | -$15.33M | -$15.12M | -$14.63M | -$14.48M |
| Total Stockholders' Equity | -$2.65M | -$1.93M | -$1.33M | -$1.09M | -$1.14M | -$951K | -$520K | -$467K |
| Total Equity | -$2.65M | -$1.93M | -$1.33M | -$1.09M | -$1.14M | -$951K | -$520K | -$467K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Net Income | -$1.18M | -$985K | -$237K | -$766K | -$1.41M |
| Depreciation & Amortization | -- | -- | -- | -- | $62K |
| Stock-Based Compensation | $21K | $106K | $4.3K | $15K | $119K |
| Change in Payables | $327K | $112K | -$14K | $105K | $47K |
| Operating Cash Flow | -$418K | -$238K | -$444K | -$263K | -$970K |
| Investing Cash Flow | -- | -- | $100K | -- | -- |
| Common Stock Issued | $100K | -- | $560K | -- | $972K |
| Financing Cash Flow | $413K | $35K | $560K | -- | $1.15M |
| Net Change in Cash | -$4.7K | -$203K | $216K | -$263K | $178K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$236K | -$190K | -$327K | -$595K | -$240K | -$136K | -$211K | -$493K |
| Stock-Based Compensation | -- | -- | -- | $0 | $0 | $0 | $21K | $62K |
| Change in Payables | $95K | $88K | $86K | $289K | -$121K | $76K | $83K | $28K |
| Operating Cash Flow | -$40K | $6.2K | -$9.4K | -$82K | -$107K | -$218K | -$10.0K | $2.9K |
| Net Change in Cash | $90K | $0 | -$9.4K | -$44K | -$178K | $227K | -$10.0K | -$12K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Return on Equity (ROE) | -- | -- | -- | -- | -466.9% |
| Return on Assets (ROA) | -2980.9% | -1367.4% | -39.9% | -189.5% | -201.8% |
| Current Ratio | 0.02x | 0.07x | 0.31x | 0.00x | 0.67x |
| Quick Ratio | 0.00x | 0.01x | 0.30x | 0.00x | 0.67x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Assets (ROA) | -1504.4% | -- | -- | -2980.9% | -518.0% | -260.4% | -1625.8% | -1367.4% |
| Current Ratio | 0.03x | -- | -- | 0.02x | 0.14x | 0.26x | 0.05x | 0.07x |
| Quick Ratio | 0.03x | -- | -- | 0.00x | 0.03x | 0.16x | 0.00x | 0.01x |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -2941.2% | -- | -- | -- | -- |